Allison Sayre, MSN, WHNP
In clinical practice, isolated lab values often fall short of explaining why patients feel fatigued, inflamed, or hormonally dysregulated. The Energy Allocation System (EAS) offers a new perspective. Rather than viewing hormones in isolation, it frames physiology as a coordinated response to how the body allocates finite energy resources. [1]
Within this framework, certain lab ratios become especially meaningful as clues to the body’s energy strategy. Rather than reflecting static hormone levels, they reveal dynamic patterns of energy distribution across the hypothalamic–pituitary–thyroid (HPT) axis, hypothalamic–pituitary–gonadal (HPG) axis, and metabolic systems. These ratios may not be explicitly stated on a laboratory result, suggesting a calculator or a sharp brain may be required.
Free T3 to Free T4 Ratio: A Window Into Metabolic Throughput
The fT3 to fT4 ratio reflects how effectively the body converts T4 into the active hormone T3. A lower ratio suggests impaired peripheral conversion, often seen under stress, inflammation, or nutrient insufficiency. [2-5]
From an EAS perspective, this is not simply thyroid dysfunction, but it is a strategic shift where the body is downregulating metabolic throughput to conserve energy. Reduced T3 signaling slows mitochondrial activity, helping preserve limited bioenergetic reserves when demand exceeds supply. [1]
Clinically, this can present as fatigue, cold intolerance, or slowed recovery despite a normal TSH. The ratio, not the isolated value, tells the story.
Importantly, a lower fT3 to fT4 ratio should not automatically be interpreted as failure, but as context. Clinically, this creates an opportunity to look upstream, asking not just “is the thyroid working,” but “what is influencing conversion?” This distinction is critical for avoiding premature or unnecessary thyroid hormone replacement.
How to Calculate fT3 to fT4 ratio
*Unit alignment matters: Because fT3 is typically reported in pg/mL and fT4 in ng/dL, this calculation intentionally preserves clinical convention rather than converting units.
Clinical Interpretation
|
fT3:fT4 Ratio |
Interpretation |
Clinical Context |
|
> 3.5 – 4.5 |
Robust conversion |
Adequate metabolic throughput; often seen in well-resourced states |
|
~ 2.5 – 3.5 |
Mid-range / adaptive |
Context-dependent; may reflect balanced or mildly constrained energy allocation |
|
< 2.5 |
Reduced conversion |
Suggests impaired peripheral conversion; often seen with stress, inflammation, or nutrient insufficiency |
|
< 2.0 |
Markedly reduced conversion |
Strong signal of downregulated metabolic throughput; consider systemic constraints |
These ranges are clinical heuristics, not diagnostic cutoffs.
LH to FSH Ratio: Signaling Reproductive Investment vs. Suppression
In premenopausal women, the luteinizing hormone (LH) to follicle-stimulating hormone (FSH) ratio can provide insight into how the HPG axis is allocating energy.
For example, in functional hypothalamic amenorrhea (FHA), the LH to FSH ratio is typically low, often ≤1. This reflects hypothalamic suppression driven by factors such as stress, undernutrition, or excessive exercise. In EAS terms, the body is deprioritizing reproductive investment to conserve energy for survival. [6]
In contrast, a higher LH to FSH ratio, often seen in polycystic ovarian syndrome (PCOS) (commonly ≥2), reflects dysregulated signaling within the HPG axis. This pattern is not simply excess activity, but one of dysregulated signaling. It suggests misaligned allocation, often occurring alongside insulin resistance and metabolic strain. [7]
So, the ratio helps distinguish two very different states:
- Low ratio → energy conservation and suppression
- High ratio → dysregulated signaling under metabolic pressure
From an EAS perspective, both patterns reflect constraint, just expressed differently. In FHA, the system suppresses reproductive signaling to preserve energy. In PCOS, signaling persists, but in a discoordinated way that is often energetically inefficient. This distinction is clinically important, as these presentations require very different interventions despite both involving disruption of the HPG axis.
It is important to note that in menstruating women, the LH to FSH ratio is most meaningful when measured in the early follicular phase (cycle days 2–5). [8]
Triglyceride to HDL Ratio: A Marker of Metabolic Flexibility
The triglyceride (TG) to high-density lipoprotein (HDL) ratio is a powerful, accessible marker of metabolic health, with a higher ratio being strongly associated with insulin resistance, metabolic syndrome, and cardiovascular risk. [9]
Within the EAS framework, the TG to HDL ratio reflects how efficiently the body can switch between fuel sources. A high TG to HDL ratio suggests metabolic inflexibility. Energy is not being effectively processed or distributed, increasing the physiological cost of adaptation. [1]
This aligns with a constrained bioenergetic state where:
- Lipid handling is impaired
- Inflammation may be elevated
- Energy production becomes less efficient
In other words, the system is working harder to produce less usable energy.
When evaluating a lipid panel, clinicians should also consider familial hypertriglyceridemia and recognize that elevated triglycerides may cause acute pancreatitis. Common causes of elevated triglycerides include insulin resistance and hyperinsulinemia, excess intake of refined carbohydrates and fructose, alcohol use, obesity and positive energy balance (excess calories), hypothyroidism, certain medications including oral estrogens (particularly higher-dose or first-pass hepatic formulations), non-selective beta-blockers, thiazide diuretics, systemic corticosteroids, atypical antipsychotics, and retinoids such as isotretinoin. Depending on which lipid panel is ordered, this ratio may be explicitly stated in a laboratory report.
Clinically, this ratio can serve as a bridge between metabolic and endocrine health. A persistently elevated TG to HDL ratio may help explain why patients struggle with symptoms such as fatigue, weight resistance, or hormonal dysregulation despite otherwise “normal” labs. It reflects a system that is less metabolically flexible, and therefore less resilient to stressors.
Bringing It Together
Each of these ratios offers a snapshot of how the body is allocating energy:
- fT3:fT4 → metabolic pace and mitochondrial throughput
- LH:FSH → reproductive investment vs. suppression
- TG:HDL → metabolic flexibility and efficiency
Viewed together, they move us beyond isolated labs toward pattern recognition. And within the EAS framework, those patterns reflect something deeper: not just dysfunction, but the body’s attempt to adapt under constraint.
Understanding that shift changes how we interpret labs, and more importantly, how we support recovery.
Disclaimer:
The information provided is for educational purposes only. Consult your physician or healthcare practitioner if you have specific questions before instituting any changes in your daily lifestyle including changes in diet, exercise, and supplement use.
Allison Sayre, MSN, WHNP is a board-certified women’s health nurse practitioner with advanced expertise in hormonal health, integrative gynecology, and patient-centered care across the lifespan. She holds a Master of Science in Nursing and has served as both a clinical provider and educator in functional and conventional women’s health settings. At ARG, Allison contributes to medical education, clinical protocol development, and strategic content that supports the evolving needs of women's healthcare practitioners.
